A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.

导出 OA

翻译打印收藏纠错

作者： Adriana T,Lopez ^[1] ; Larisa,Geskin ^[2]

作者单位： Columbia University College of Physicians and Surgeons, New York, New York, USA. ^[1] Department of Dermatology, Columbia University Medical Center, New York, New York, USA ljg2145@cumc.columbia.edu. ^[2]

主题词老年人(Aged);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);氯倍他索(Clobetasol);女(雌)性(Female);人类(Humans);免疫疗法(Immunotherapy);肺肿瘤(Lung Neoplasms);类天疱疮, 大疱性(Pemphigoid, Bullous);泼尼松(Prednisone);皮肤(Skin)

DOI 10.1634/theoncologist.2018-0128

PMID 30018132

发布时间 2024-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

The oncologist

2018年23卷10期

1119-1126页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.

The oncologist

相似文献

The oncologist

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.

The oncologist

相似文献

The oncologist

相关期刊

检索历史清除